Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $20.00 billion. The enterprise value is $20.51 billion.
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.37 million shares outstanding. The number of shares has decreased by -0.75% in one year.
| Current Share Class | 70.37M |
| Shares Outstanding | 70.37M |
| Shares Change (YoY) | -0.75% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 102.19% |
| Float | 70.06M |
Valuation Ratios
The trailing PE ratio is 51.23 and the forward PE ratio is 63.86. Insulet's PEG ratio is 2.46.
| PE Ratio | 51.23 |
| Forward PE | 63.86 |
| PS Ratio | 9.04 |
| Forward PS | 7.46 |
| PB Ratio | 14.99 |
| P/TBV Ratio | 17.00 |
| P/FCF Ratio | 68.80 |
| P/OCF Ratio | 49.32 |
| PEG Ratio | 2.46 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 48.32, with an EV/FCF ratio of 70.40.
| EV / Earnings | 51.00 |
| EV / Sales | 9.33 |
| EV / EBITDA | 48.32 |
| EV / EBIT | 60.19 |
| EV / FCF | 70.40 |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 1.31.
| Current Ratio | 4.47 |
| Quick Ratio | 3.24 |
| Debt / Equity | 1.31 |
| Debt / EBITDA | 4.05 |
| Debt / FCF | 6.00 |
| Interest Coverage | 8.27 |
Financial Efficiency
Return on equity (ROE) is 37.92% and return on invested capital (ROIC) is 8.03%.
| Return on Equity (ROE) | 37.92% |
| Return on Assets (ROA) | 6.94% |
| Return on Invested Capital (ROIC) | 8.03% |
| Return on Capital Employed (ROCE) | 11.37% |
| Revenue Per Employee | $563,821 |
| Profits Per Employee | $103,128 |
| Employee Count | 3,900 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 1.49 |
Taxes
| Income Tax | -108.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.94% in the last 52 weeks. The beta is 1.35, so Insulet's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +43.94% |
| 50-Day Moving Average | 307.24 |
| 200-Day Moving Average | 271.53 |
| Relative Strength Index (RSI) | 33.55 |
| Average Volume (20 Days) | 706,901 |
Short Selling Information
The latest short interest is 2.21 million, so 3.15% of the outstanding shares have been sold short.
| Short Interest | 2.21M |
| Short Previous Month | 1.91M |
| Short % of Shares Out | 3.15% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, Insulet had revenue of $2.20 billion and earned $402.20 million in profits. Earnings per share was $5.55.
| Revenue | 2.20B |
| Gross Profit | 1.55B |
| Operating Income | 340.80M |
| Pretax Income | 267.50M |
| Net Income | 402.20M |
| EBITDA | 424.50M |
| EBIT | 340.80M |
| Earnings Per Share (EPS) | $5.55 |
Full Income StatementBalance Sheet
The company has $1.28 billion in cash and $1.75 billion in debt, giving a net cash position of -$465.50 million or -$6.61 per share.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 1.75B |
| Net Cash | -465.50M |
| Net Cash Per Share | -$6.61 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 18.91 |
| Working Capital | 1.81B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $406.50 million and capital expenditures -$115.10 million, giving a free cash flow of $291.40 million.
| Operating Cash Flow | 406.50M |
| Capital Expenditures | -115.10M |
| Free Cash Flow | 291.40M |
| FCF Per Share | $4.14 |
Full Cash Flow StatementMargins
Gross margin is 70.39%, with operating and profit margins of 15.50% and 18.29%.
| Gross Margin | 70.39% |
| Operating Margin | 15.50% |
| Pretax Margin | 13.34% |
| Profit Margin | 18.29% |
| EBITDA Margin | 19.31% |
| EBIT Margin | 15.50% |
| FCF Margin | 13.25% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.75% |
| Shareholder Yield | 0.75% |
| Earnings Yield | 2.01% |
| FCF Yield | 1.45% |
Dividend DetailsAnalyst Forecast
The average price target for Insulet is $320.11, which is 12.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $320.11 |
| Price Target Difference | 12.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 16.34% |
| EPS Growth Forecast (5Y) | 8.93% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 5.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.95 |
| Piotroski F-Score | 6 |
